JP2020063263A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020063263A5 JP2020063263A5 JP2019217044A JP2019217044A JP2020063263A5 JP 2020063263 A5 JP2020063263 A5 JP 2020063263A5 JP 2019217044 A JP2019217044 A JP 2019217044A JP 2019217044 A JP2019217044 A JP 2019217044A JP 2020063263 A5 JP2020063263 A5 JP 2020063263A5
- Authority
- JP
- Japan
- Prior art keywords
- hematopoietic stem
- cells
- pge
- activity
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims 23
- 239000000203 mixture Substances 0.000 claims 13
- 150000001875 compounds Chemical class 0.000 claims 8
- 230000000694 effects Effects 0.000 claims 8
- 150000003180 prostaglandins Chemical class 0.000 claims 6
- 229940094443 oxytocics prostaglandins Drugs 0.000 claims 5
- 210000004027 cell Anatomy 0.000 claims 3
- QAOBBBBDJSWHMU-WMBBNPMCSA-N 16,16-dimethylprostaglandin E2 Chemical compound CCCCC(C)(C)[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O QAOBBBBDJSWHMU-WMBBNPMCSA-N 0.000 claims 2
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims 2
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims 2
- 210000001185 bone marrow Anatomy 0.000 claims 2
- 238000002659 cell therapy Methods 0.000 claims 2
- 210000004700 fetal blood Anatomy 0.000 claims 2
- 210000005259 peripheral blood Anatomy 0.000 claims 2
- 239000011886 peripheral blood Substances 0.000 claims 2
- 239000013603 viral vector Substances 0.000 claims 2
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 210000000130 stem cell Anatomy 0.000 claims 1
- 238000001890 transfection Methods 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023001015A JP2023052244A (ja) | 2008-11-06 | 2023-01-06 | 造血幹細胞の生着手順を強化するための材料および方法 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11201808P | 2008-11-06 | 2008-11-06 | |
| US61/112,018 | 2008-11-06 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017195168A Division JP2018048156A (ja) | 2008-11-06 | 2017-10-05 | 造血幹細胞の生着手順を強化するための材料および方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023001015A Division JP2023052244A (ja) | 2008-11-06 | 2023-01-06 | 造血幹細胞の生着手順を強化するための材料および方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020063263A JP2020063263A (ja) | 2020-04-23 |
| JP2020063263A5 true JP2020063263A5 (https=) | 2020-09-03 |
Family
ID=42153284
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011534934A Expired - Fee Related JP5846915B2 (ja) | 2008-11-06 | 2009-11-06 | 造血幹細胞の生着手順を強化するための材料および方法 |
| JP2015134076A Expired - Fee Related JP6632822B2 (ja) | 2008-11-06 | 2015-07-03 | 造血幹細胞の生着手順を強化するための材料および方法 |
| JP2017195168A Withdrawn JP2018048156A (ja) | 2008-11-06 | 2017-10-05 | 造血幹細胞の生着手順を強化するための材料および方法 |
| JP2019217044A Withdrawn JP2020063263A (ja) | 2008-11-06 | 2019-11-29 | 造血幹細胞の生着手順を強化するための材料および方法 |
| JP2023001015A Pending JP2023052244A (ja) | 2008-11-06 | 2023-01-06 | 造血幹細胞の生着手順を強化するための材料および方法 |
Family Applications Before (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011534934A Expired - Fee Related JP5846915B2 (ja) | 2008-11-06 | 2009-11-06 | 造血幹細胞の生着手順を強化するための材料および方法 |
| JP2015134076A Expired - Fee Related JP6632822B2 (ja) | 2008-11-06 | 2015-07-03 | 造血幹細胞の生着手順を強化するための材料および方法 |
| JP2017195168A Withdrawn JP2018048156A (ja) | 2008-11-06 | 2017-10-05 | 造血幹細胞の生着手順を強化するための材料および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023001015A Pending JP2023052244A (ja) | 2008-11-06 | 2023-01-06 | 造血幹細胞の生着手順を強化するための材料および方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (5) | US9107909B2 (https=) |
| EP (3) | EP3031907B1 (https=) |
| JP (5) | JP5846915B2 (https=) |
| CN (4) | CN102245758A (https=) |
| AU (4) | AU2009313290B2 (https=) |
| CA (3) | CA2742876C (https=) |
| ES (1) | ES2845641T3 (https=) |
| PT (1) | PT3031907T (https=) |
| WO (1) | WO2010054271A1 (https=) |
| ZA (1) | ZA201804932B (https=) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101441843B1 (ko) | 2005-10-18 | 2014-09-17 | 내셔날 쥬이쉬 헬스 | 조건부 불멸화 장기 줄기 세포 및 상기 세포의 제조 및 사용 방법 |
| EP2285832B1 (en) | 2008-05-16 | 2020-08-26 | Taiga Biotechnologies, Inc. | Antibodies and processes for preparing the same |
| EP2318435B1 (en) | 2008-08-28 | 2015-12-23 | Taiga Biotechnologies, Inc. | Modulators of myc, methods of using the same, and methods of identifying agents that modulate myc |
| PT3031907T (pt) | 2008-11-06 | 2021-01-28 | Univ Indiana Res & Tech Corp | Materiais e métodos para melhorar procedimentos de enxerto de células estaminais hematopoiéticas |
| US10813917B2 (en) | 2009-12-11 | 2020-10-27 | Medregen, Llc | Treatment methods utilizing stem cell mobilizers and immunosuppressive agents |
| EP2603227B1 (en) * | 2010-08-12 | 2017-10-04 | Fate Therapeutics, Inc. | Improved hematopoietic stem and progenitor cell therapy |
| EA033717B1 (ru) * | 2011-01-13 | 2019-11-19 | Scipharm Sarl | Способ ex vivo предварительной обработки гемопоэтических стволовых клеток и фармацевтическая композиция для улучшения приживления гемопоэтических стволовых клеток |
| PT2760994T (pt) * | 2011-09-30 | 2017-08-24 | Bluebird Bio Inc | Compostos para melhor transdução viral |
| EP3785767A1 (en) | 2011-12-02 | 2021-03-03 | Fate Therapeutics, Inc. | Enhanced stem cell composition |
| US10111907B2 (en) * | 2011-12-02 | 2018-10-30 | Fate Therapeutics, Inc. | Methods of treating ischemia |
| WO2013130499A1 (en) * | 2012-02-29 | 2013-09-06 | University Of Virginia Patent Foundation | Compositions and methods for cxcr4 signaling and umbilical cord blood stem cell engraftment |
| WO2014015318A1 (en) * | 2012-07-19 | 2014-01-23 | Bluebird Bio, Inc. | Soluble compounds for improved gene therapy methods |
| JP6285930B2 (ja) * | 2012-07-20 | 2018-02-28 | タイガ バイオテクノロジーズ，インク． | 造血コンパートメントの再構築及び自家再構築の増進 |
| US20150216903A1 (en) * | 2012-08-10 | 2015-08-06 | Bluebird Bio, Inc. | Compounds for improved viral transduction |
| JP2016516672A (ja) | 2013-02-28 | 2016-06-09 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 幹細胞を動員するための方法および組成物 |
| US10272115B2 (en) | 2013-03-11 | 2019-04-30 | Taiga Biotechnologies, Inc. | Production and use of red blood cells |
| US9943545B2 (en) | 2013-03-15 | 2018-04-17 | Fate Therapeutics, Inc. | Stem cell culture media and methods of enhancing cell survival |
| US10851412B2 (en) | 2013-03-15 | 2020-12-01 | Fate Therapeutics, Inc. | Cell potency assay for therapeutic potential |
| DK3030232T3 (da) | 2013-04-29 | 2022-10-10 | Medregen Llc | Sårheling via autolog stamecellemobilisering |
| KR101489861B1 (ko) * | 2013-05-07 | 2015-02-05 | 경북대학교 산학협력단 | Amd3100을 포함하는 골질환 예방 또는 치료용 조성물 |
| US20180112180A1 (en) | 2015-01-26 | 2018-04-26 | Fate Therapeutics, Inc. | Cells with increased immuno-regulatory properties and methods for their use and manufacture |
| CN104774806B (zh) * | 2015-04-09 | 2019-02-15 | 广州赛莱拉干细胞科技股份有限公司 | 一种胎盘造血干细胞的制备方法 |
| RU2018106515A (ru) | 2015-07-21 | 2019-08-21 | Зе Чилдрен'С Медикал Сентер Корпорейшн | Pd-l1-экспрессирующие гемопоэтические стволовые клетки и применения |
| WO2017139576A1 (en) | 2016-02-12 | 2017-08-17 | Bluebird Bio, Inc. | Vcn enhancer compositions and methods of using the same |
| WO2017139561A1 (en) | 2016-02-12 | 2017-08-17 | Bluebird Bio, Inc. | Vcn enhancer compositions and methods of using the same |
| JP2019507596A (ja) * | 2016-02-26 | 2019-03-22 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 生着性の高い造血幹細胞 |
| US20200224165A1 (en) * | 2016-07-22 | 2020-07-16 | Senlin Li | Methods and compositions for rejuvenation |
| KR20190092472A (ko) | 2016-12-02 | 2019-08-07 | 타이가 바이오테크놀로지스, 인코포레이티드 | 나노입자 제제 |
| JP7175277B2 (ja) * | 2017-01-27 | 2022-11-18 | チルドレンズ ホスピタル メディカル センター | 造血幹細胞の生着活性を向上させる方法 |
| US10149898B2 (en) | 2017-08-03 | 2018-12-11 | Taiga Biotechnologies, Inc. | Methods and compositions for the treatment of melanoma |
| US11213546B2 (en) | 2017-09-07 | 2022-01-04 | Emory University | Methods to mobilize tissue resident cells for adoptive t cell therapy |
| WO2019060708A1 (en) | 2017-09-22 | 2019-03-28 | The Children's Medical Center Corporation | TREATMENT OF TYPE 1 DIABETES AND AUTOIMMUNE DISEASES OR DISORDERS |
| FR3074189A1 (fr) * | 2017-11-30 | 2019-05-31 | Assistance Publique - Hopitaux De Paris | Methode de generation de greffons de cellules souches hematopoietiques |
| CN108404112B (zh) * | 2018-04-01 | 2020-05-12 | 北京诺赛启研再生医学研究院有限公司 | 提高造血干细胞归巢及植入率的方法及其试剂 |
| EP3647413A1 (en) * | 2018-10-31 | 2020-05-06 | Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas O.A., M.P. (CIEMAT) | Improvements for performing and facilitating the recovery after hematopoietic stem cell transplantation |
| WO2020210231A1 (en) | 2019-04-08 | 2020-10-15 | Taiga Biotechnologies, Inc. | Compositions and methods for the cry opreservation of immune cells |
| EP3969041A4 (en) | 2019-05-14 | 2023-05-10 | Taiga Biotechnologies, Inc. | COMPOSITIONS AND METHODS FOR TREATMENT OF T-CELL DEPLETION |
| EP4129911A4 (en) | 2020-03-31 | 2023-10-04 | Denka Company Limited | Alumina powder, resin composition, and heat dissipation component |
| CN116509834B (zh) * | 2023-01-20 | 2025-05-13 | 东北师范大学 | 化合物在制备造血干/祖细胞增殖和损伤修复药物中的应用 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5399493A (en) * | 1989-06-15 | 1995-03-21 | The Regents Of The University Of Michigan | Methods and compositions for the optimization of human hematopoietic progenitor cell cultures |
| JPH08205860A (ja) * | 1994-01-21 | 1996-08-13 | Usa Government | 造血細胞の膨大化および移植方法 |
| US5928638A (en) * | 1996-06-17 | 1999-07-27 | Systemix, Inc. | Methods for gene transfer |
| EP1438075A4 (en) * | 2001-10-02 | 2006-04-19 | Inst Clayton De La Rech | METHOD AND COMPOSITIONS ASSOCIATED WITH LENTIVIRAL VECTORS WITH LIMITED EXPRESSION AND ITS APPLICATIONS |
| US20050163760A1 (en) | 2001-12-06 | 2005-07-28 | Nathalie Cartier-Lacave | Use of cd34+ hematopoietic progenitor cells for the treatment of cns disorders |
| AU2003214920A1 (en) * | 2002-02-04 | 2003-09-02 | Millennium Pharmaceuticals Inc. | Methods and compositions for treating hematological disorders |
| AU2004227205B2 (en) | 2003-04-08 | 2010-06-10 | Yeda Research And Development Co. Ltd | Stem cells having increased sensitivity to a chemoattractant and methods of generating and using same |
| IL158868A0 (en) | 2003-11-13 | 2004-05-12 | Yeda Res & Dev | Methods of generating and using stem cells enriched with immature primitive progenitor |
| EP1760071A4 (en) * | 2004-06-23 | 2008-03-05 | Ono Pharmaceutical Co | COMPOUND WITH S1P RECEPTOR BINDING ABILITY AND USE THEREOF |
| US20080021078A1 (en) | 2006-07-18 | 2008-01-24 | Horizon Therapeutics, Inc. | Methods and medicaments for administration of ibuprofen |
| US20070087988A1 (en) * | 2005-09-30 | 2007-04-19 | New York University | Hematopoietic progenitor kinase 1 for modulation of an immune response |
| JP2007099724A (ja) | 2005-10-06 | 2007-04-19 | Shizuoka Prefecture | スルファチドを標的とした抗ウイルス剤 |
| US8076315B2 (en) | 2005-10-14 | 2011-12-13 | The Board Of Trustees Of The University Of Illinois | Pharmacological treatments for sleep disorders (apnoe) with prostanoid receptor antagonists |
| EP3424507A1 (en) | 2006-03-24 | 2019-01-09 | Children's Medical Center Corporation | Method to modulate hematopoietic stem cell growth |
| EP2049129B1 (en) | 2006-06-22 | 2013-06-12 | Yeda Research And Development Co., Ltd. | Catecholamine receptor modulation |
| EP2679221B1 (en) | 2006-10-20 | 2020-09-23 | Children's Medical Center Corporation | Method to enhance tissue regeneration |
| US9394520B2 (en) * | 2006-12-08 | 2016-07-19 | University Of Rochester | Expansion of hematopoietic stem cells |
| US8598328B2 (en) | 2006-12-13 | 2013-12-03 | National University Corporation Nagoya University | Tol1 factor transposase and DNA introduction system using the same |
| PT3031907T (pt) | 2008-11-06 | 2021-01-28 | Univ Indiana Res & Tech Corp | Materiais e métodos para melhorar procedimentos de enxerto de células estaminais hematopoiéticas |
| EP2408444A4 (en) | 2009-03-19 | 2012-09-26 | Fate Therapeutics Inc | COMPOSITIONS WITH CYCLIC AMP AMPLIFIERS AND / OR EP LIGANDS, AND METHOD FOR THEIR PRODUCTION AND USE |
| PT2760994T (pt) | 2011-09-30 | 2017-08-24 | Bluebird Bio Inc | Compostos para melhor transdução viral |
-
2009
- 2009-11-06 PT PT161535265T patent/PT3031907T/pt unknown
- 2009-11-06 EP EP16153526.5A patent/EP3031907B1/en not_active Revoked
- 2009-11-06 JP JP2011534934A patent/JP5846915B2/ja not_active Expired - Fee Related
- 2009-11-06 CA CA2742876A patent/CA2742876C/en active Active
- 2009-11-06 EP EP20195600.0A patent/EP3824884A1/en not_active Withdrawn
- 2009-11-06 CN CN2009801495225A patent/CN102245758A/zh active Pending
- 2009-11-06 US US13/128,074 patent/US9107909B2/en active Active
- 2009-11-06 CA CA3012803A patent/CA3012803C/en active Active
- 2009-11-06 CN CN201710777354.0A patent/CN107630001A/zh active Pending
- 2009-11-06 CN CN201710777353.6A patent/CN107523587A/zh active Pending
- 2009-11-06 EP EP09825528.4A patent/EP2362733B1/en not_active Not-in-force
- 2009-11-06 CA CA3203374A patent/CA3203374A1/en active Pending
- 2009-11-06 AU AU2009313290A patent/AU2009313290B2/en not_active Ceased
- 2009-11-06 ES ES16153526T patent/ES2845641T3/es active Active
- 2009-11-06 WO PCT/US2009/063654 patent/WO2010054271A1/en not_active Ceased
- 2009-11-06 CN CN201810232658.3A patent/CN108379292A/zh active Pending
-
2014
- 2014-06-27 US US14/318,167 patent/US10213460B2/en active Active
-
2015
- 2015-03-04 US US14/638,676 patent/US9675641B2/en not_active Expired - Fee Related
- 2015-07-03 JP JP2015134076A patent/JP6632822B2/ja not_active Expired - Fee Related
-
2016
- 2016-07-21 AU AU2016206316A patent/AU2016206316C1/en not_active Ceased
-
2017
- 2017-05-11 US US15/592,375 patent/US11241454B2/en not_active Expired - Fee Related
- 2017-10-05 JP JP2017195168A patent/JP2018048156A/ja not_active Withdrawn
-
2018
- 2018-07-23 ZA ZA2018/04932A patent/ZA201804932B/en unknown
- 2018-10-08 AU AU2018241208A patent/AU2018241208B2/en not_active Ceased
-
2019
- 2019-11-29 JP JP2019217044A patent/JP2020063263A/ja not_active Withdrawn
-
2020
- 2020-08-21 AU AU2020220191A patent/AU2020220191B2/en not_active Ceased
-
2021
- 2021-12-14 US US17/550,737 patent/US20220313735A1/en not_active Abandoned
-
2023
- 2023-01-06 JP JP2023001015A patent/JP2023052244A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020063263A5 (https=) | ||
| Benjamin et al. | TALEN gene editing takes aim on HIV | |
| SA517390590B1 (ar) | Ix عامل معدل، وتركيبات وطرق واستخدامات لنقل الجين إلى الخلايا، والأعضاء والأنسجة | |
| MY197586A (en) | Adenovirus armed with bispecific t cell engager (bite) | |
| ES2900560T3 (es) | Terapia génica. | |
| CO2021006362A2 (es) | Construcciones de ácido nucleico y métodos de uso | |
| CO2020010376A2 (es) | Uso de vectores lentivirales que expresan el factor viii | |
| MX2025013445A (es) | Generacion de pah humana mejorada para el tratamiento de pku grave mediante terapia de sustitucion de genes dirigida al higado | |
| MY209906A (en) | Lipid nanoparticle formulations of non-viral, capsid-free dna vectors | |
| Kawashima et al. | Properties of dental pulp–derived mesenchymal stem cells and the effects of culture conditions | |
| MX2021001292A (es) | Metodos para la modificacion genica de celulas hematopoyeticas. | |
| MX2020005663A (es) | Terapia genica para mucopolisacaridosis iii a. | |
| MX2024005314A (es) | Particulas virales redirigidas a musculo esqueletico. | |
| CO2023015911A2 (es) | Vectores aavrh74 para la terapia génica de distrofias musculares. | |
| WO2021081457A3 (en) | Methods and agents for enhancing t cell therapies | |
| Singh et al. | Mesenchymal stromal cells, metabolism, and mitochondrial transfer in bone marrow normal and malignant hematopoiesis | |
| Zhou et al. | IFNα‐expressing amniotic fluid‐derived mesenchymal stem cells migrate to and suppress HeLa cell‐derived tumors in a mouse model | |
| Díaz et al. | GFP labelling and epigenetic enzyme expression of bone marrow-derived mesenchymal stem cells from bovine foetuses | |
| Perlea et al. | Phenotype heterogeneity in dental pulp stem niches | |
| RU2019102933A (ru) | Лечение сосудистого заболевания сетчатки с использованием клеток-предшественников | |
| MX2021013597A (es) | El polipeptido ix adenoviral aumenta la productividad y la infectividad del vector adenoviral de terapia genica. | |
| CA3217059A1 (en) | Compositions for improving the transduction of cells by viral vectors | |
| Sorg et al. | O6-methylguanine-DNA-methyltransferase (MGMT) gene therapy targeting haematopoietic stem cells: studies addressing safety issues | |
| Aizenshtadt et al. | Charachterization of umbilical cord mesenchymal stromal cells during long-term expansion in vitro | |
| Hoetzenecker | Step by step toward the summit |